Current progress in γδ T-cell biology

Cellular and Molecular Immunology

Volumn 7, Issue 6, 2010, Pages 409-413

  Hao, Jianlei ^a   Wu, Xiaoli ^a   Xia, Siyuan ^a   Li, Zheng ^a   Wen, Ti ^a   Zhao, Na ^a   Wu, Zhenzhou ^a   Wang, Puyue ^a   Zhao, Liqing ^a   Yin, Zhinan ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

T cells; immunotherapy; innate immunity

Indexed keywords

4 HYDROXY 3 METHYLBUT 2 ENYL PYROPHOSPHATE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BCG VACCINE; BINDING PROTEIN; BIOLOGICAL MARKER; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD161 ANTIGEN; CD27 ANTIGEN; CD70 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR9; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; IPH 1101; IPH 1201; LYMPHOCYTE ANTIGEN RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; PROGRAMMED DEATH 1 RECEPTOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UL16 BINDING PROTEIN 1; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; BACTERIAL CLEARANCE; BACTERIAL PERITONITIS; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CELL FATE; CELL THERAPY; CELLULAR IMMUNITY; CHRONIC MYELOID LEUKEMIA; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FOOD ALLERGY; GAMMA DELTA T LYMPHOCYTE; HEPATITIS C; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNOREGULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; KIDNEY CARCINOMA; LISTERIOSIS; LIVER INJURY; LYMPHOCYTE FUNCTION; METABOLIC DISORDER; MULTIPLE MYELOMA; NONHUMAN; PARASITE CLEARANCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SKIN DEFECT; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; THYMOMA; TUBERCULOSIS; TUMOR; TUMOR IMMUNITY; WOUND HEALING;

ANIMALS; ANTIGENS; COMMUNICABLE DISEASES; HUMANS; IMMUNITY; IMMUNOTHERAPY; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA;

EID: 79951608202     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2010.50     Document Type: Review

References (68)

1. Melichar HJ, Narayan K, der SD, Hiraoka Y, Gardiol N, Jeannet G et al. Regulation of gammadelta versus alphabeta T lymphocyte differentiation by the transcription factor SOX13. Science 2007;315:230-233. (Pubitemid 46166366)
2. Lauritsen JP, Wong GW, Lee SY, Lefebvre JM, Ciofani M, Rhodes M et al. Marked induction of the helix-loop-helix protein Id3 promotes the gammadelta T cell fate and renders their functional maturation Notch independent. Immunity 2009;31:565-575.
3. Haks MC, Lefebvre JM, Lauritsen JP, Carleton M, Rhodes M, Miyazaki T et al. Attenuation of gammadelta TCR signaling efficiently diverts thymocytes to the alphabeta lineage. Immunity 2005;22:595-606. (Pubitemid 40719195)
4. Hayes SM, Li L, Love PE. TCR signal strength influences alphabeta/gammadelta lineage fate. Immunity 2005;22:583-593. (Pubitemid 40719194)
5. Kreslavsky T, Garbe AI, Krueger A, von Boehmer H. T cell receptor-instructed alphabeta versus gammadelta lineage commitment revealed by single-cell analysis. J Exp Med 2008;205:1173-1186. (Pubitemid 351679691)
6. Ciofani M, Knowles GC, Wiest DL, von Boehmer H, Zuniga-Pflucker JC. Stage-specific and differential notch dependency at the alphabeta and gammadelta T lineage bifurcation. Immunity 2006;25:105-116. (Pubitemid 44066824)
7. Garbe AI, Krueger A, Gounari F, Zuniga-Pflucker JC, von Boehmer H. Differential synergy of Notch and T cell receptor signaling determines alphabeta versus gammadelta lineage fate. J Exp Med 2006;203:1579-1590. (Pubitemid 43877617)
8. Tanigaki K, Tsuji M, Yamamoto N, Han H, Tsukada J, Inoue H et al. Regulation of alphabeta/gammadelta T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling. Immunity 2004;20:611-622. (Pubitemid 38638130)
9. Washburn T, Schweighoffer E, Gridley T, Chang D, Fowlkes BJ, Cado D et al. Notch activity influences the alphabeta versus gammadelta T cell lineage decision. Cell 1997;88:833-843. (Pubitemid 27164271)
10. Boyden LM, Lewis JM, Barbee SD, Bas A, Girardi M, Hayday AC et al. Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal gammadelta T cells. Nat Genet 2008;40:656-662. (Pubitemid 351601202)
11. Silva-Santos B, Pennington DJ, Hayday AC. Lymphotoxin-mediated regulation of gammadelta cell differentiation by alphabeta T cell progenitors. Science 2005;307:925-928. (Pubitemid 40229229)
12. Jensen KD, Su X, Shin S, Li L, Youssef S, Yamasaki S et al. Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity 2008;29:90-100.
13. + cells. Nat Immunol 2003;4:991-998. (Pubitemid 37265920)
14. Kreslavsky T, Savage AK, Hobbs R, Gounari F, Bronson R, Pereira P et al. TCR-inducible PLZF transcription factor required for innate phenotype of a subset of gammadelta T cells with restricted TCR diversity. Proc Natl Acad Sci USA 2009;106:12453-12458.
15. Yin Z, Zhang DH, Welte T, Bahtiyar G, Jung S, Liu L et al. Dominance of IL-12 over IL-4 in gamma delta T cell differentiation leads to default production of IFN-gamma: failure to down-regulate IL-12 receptor beta 2-chain expression. J Immunol 2000;164:3056-3064. (Pubitemid 30148965)
16. Yin Z, Chen C, Szabo SJ, Glimcher LH, Ray A, Craft J. T-Bet expression and failure of GATA-3 cross-regulation lead to default production of IFN-gamma by gammadelta T cells. J Immunol 2002;168:1566-1571. (Pubitemid 34135750)
17. Chen L, He W, Kim ST, Tao J, Gao Y, Chi H et al. Epigenetic and transcriptional programs lead to default IFN-gamma production by gammadelta T cells. J Immunol 2007;178:2730-2736. (Pubitemid 46333149)
18. Gao Y, Yang W, Pan M, Scully E, Girardi M, Augenlicht LH et al. Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J Exp Med 2003;198:433-442. (Pubitemid 36976054)
19. He W, Hao J, Dong S, Gao Y, Tao J, Chi H et al. Naturally activated Vgamma4 gammadelta T cells play a protective role in tumor immunity through expression of eomesodermin. J Immunol 2010;185:126-133.
20. Subauste CS, Chung JY, Do D, Koniaris AH, Hunter CA, Montoya JG et al. Preferential activation and expansion of human peripheral blood gamma delta T cells in response to Toxoplasma gondii in vitro and their cytokine production and cytotoxic activity against T. gondii-infected cells. J Clin Invest 1995;96:610-619.
21. Wang L, Das H, Kamath A, Bukowski JF. Human V gamma 2V delta 2 T cells produce IFN-gamma and TNF-alpha with an on/off/on cycling pattern in response to live bacterial products. J Immunol 2001;167:6195-6201. (Pubitemid 33081547)
22. Roark CL, French JD, Taylor MA, Bendele AM, Born WK, O'Brien RL. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells. J Immunol 2007;179:5576-5583.
23. Hamada S, Umemura M, Shiono T, Tanaka K, Yahagi A, Begum MD et al. IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver. J Immunol 2008;181:3456-3463.
24. Roark CL, Simonian PL, Fontenot AP, Born WK, O'Brien RL. Gammadelta T cells: an important source of IL-17. Curr Opin Immunol 2008;20:353-357.
25. Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009;31:321-330.
26. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009;31:331-341.
27. Ribot JC, deBarros A, Pang DJ, Neves JF, Peperzak V, Roberts SJ et al. CD27 is a thymic determinant of the balance between interferon-gamma-and interleukin 17-producing gammadelta T cell subsets. Nat Immunol 2009;10:427-436.
28. Prinz I, Sansoni A, Kissenpfennig A, Ardouin L, Malissen M, Malissen B. Visualization of the earliest steps of gammadelta T cell development in the adult thymus. Nat Immunol 2006;7:995-1003. (Pubitemid 44263914)
29. O'Brien RL, Roark CL, Jin N, Aydintug MK, French JD, Chain JL et al. gammadelta T-cell receptors: functional correlations. Immunol Rev 2007;215:77-88. (Pubitemid 46212231)
30. Crowley MP, Reich Z, Mavaddat N, Altman JD, Chien Y. The recognition of the nonclassical major histocompatibility complex (MHC) class I molecule, T10, by the gammadelta T cell, G8. J Exp Med 1997;185:1223-1230. (Pubitemid 27172903)
31. Matis LA, Cron R, Bluestone JA. Major histocompatibility complex-linked specificity of gamma delta receptor-bearing T lymphocytes. Nature 1987;330:262-264. (Pubitemid 18006421)
32. Shin S, El-Diwany R, Schaffert S, Adams EJ, Garcia KC, Pereira P et al. Antigen recognition determinants of gammadelta T cell receptors. Science 2005;308:252-255. (Pubitemid 40558860)
33. Adams EJ, Strop P, Shin S, Chien YH, Garcia KC. An autonomous CDR3delta is sufficient for recognition of the nonclassical MHC class I molecules T10 and T22 by gammadelta T cells. Nat Immunol 2008;9:777-784. (Pubitemid 351859161)
34. -CD8-cytolytic T lymphocytes. Nature 1989;341:447-450. (Pubitemid 19241915)
35. Spada FM, Grant EP, Peters PJ, Sugita M, Melian A, Leslie DS et al. Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med 2000;191:937-948.
36. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 1998;279:1737-1740. (Pubitemid 28164472)
37. Tanaka Y, Morita CT, Nieves E, Brenner MB, Bloom BR. Natural and synthetic nonpeptide antigens recognized by human gamma delta T cells. Nature 1995;375:155-158.
38. Scotet E, Martinez LO, Grant E, Barbaras R, Jeno P, Guiraud M et al. Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPaserelated structure and apolipoprotein A-I. Immunity 2005;22:71-80. (Pubitemid 40143452)
39. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 2000;1:119-126.
40. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285:727-729.
41. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005;23:515-548. (Pubitemid 40563179)
42. Born WK, Yin Z, Hahn YS, Sun D, O'Brien RL. Analysis of gammadelta T cell functions in the mouse. J Immunol 2010;184:4055-4061.
43. Bonneville M, O'Brien RL, Born WK. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol 2010;10:467-478.
44. Peng G, Wang HY, Peng W, Kiniwa Y, Seo KH, Wang RF. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique Toll-like receptor signaling pathway. Immunity 2007;27:334-348. (Pubitemid 47284914)
45. Vincent MS, Roessner K, Lynch D, Wilson D, Cooper SM, Tschopp J et al. Apoptosis of Fashigh CD41 synovial T cells by Borrelia-reactive Fas-ligandhigh gammadelta T cells in Lyme arthritis. J Exp Med 1996;184:2109-2118.
46. Hayday AC. gammadelta cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol 2000;18:975-1026. (Pubitemid 30365402)
47. Vermijlen D, Brouwer M, Donner C, Liesnard C, Tackoen M, van Rysselberge M et al. Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med 2010;207:807-821.
48. Mombaerts P, Arnoldi J, Russ F, Tonegawa S, Kaufmann SH. Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen. Nature 1993;365:53-56. (Pubitemid 23305567)
49. + T cells during mycobacterial infections. Science 2002;295:2255-2258. (Pubitemid 34258837)
50. Hiromatsu K, Yoshikai Y, Matsuzaki G, Ohga S, Muramori K, Matsumoto K et al. A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes in mice. J Exp Med 1992;175:49-56.
51. Dieli F, Caccamo N, Meraviglia S, Ivanyi J, Sireci G, Bonanno CT et al. Reciprocal stimulation of gammadelta T cells and dendritic cells during the anti-mycobacterial immune response. Eur J Immunol 2004;34:3227-3235. (Pubitemid 39549401)
52. O'Brien RL, Happ MP, Dallas A, Palmer E, Kubo R, Born WK. Stimulation of a major subset of lymphocytes expressing T cell receptor gamma delta by an antigen derived from Mycobacterium tuberculosis. Cell 1989;57:667-674. (Pubitemid 19140647)
53. French JD, Roark CL, Born WK, O'Brien RL. gammadelta T cell homeostasis is established in competition with alphabeta T cells and NK cells. Proc Natl Acad Sci USA 2005;102:14741-14746. (Pubitemid 41457126)
54. Constant P, Davodeau F, Peyrat MA, Poquet Y, Puzo G, Bonneville M et al. Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science 1994;264:267-270.
55. Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R et al. Regulation of cutaneous malignancy by gammadelta T cells. Science 2001;294:605-609. (Pubitemid 32999559)
56. + and TCRalphabeta1 T cells to different stages of chemically induced skin cancer. J Exp Med 2003;198:747-755. (Pubitemid 37087774)
57. Kabelitz D, Wesch D, He W. Perspectives of gammadelta T cells in tumor immunology. Cancer Res 2007;67:5-8. (Pubitemid 46142752)
58. Jameson J, Ugarte K, Chen N, Yachi P, Fuchs E, Boismenu R et al. A role for skin gammadelta T cells in wound repair. Science 2002;296:747-749. (Pubitemid 34442005)
59. Jameson JM, Cauvi G, Witherden DA, Havran WL. A keratinocyte-responsive gamma delta TCR is necessary for dendritic epidermal T cell activation by damaged keratinocytes and maintenance in the epidermis. J Immunol 2004;172:3573-3579. (Pubitemid 38337938)
60. Sharp LL, Jameson JM, Cauvi G, Havran WL. Dendritic epidermal T cells regulate skin homeostasis through local production of insulin-like growth factor 1. Nat Immunol 2005;6:73-79. (Pubitemid 40136698)
61. Girardi M, Lewis JM, Filler RB, Hayday AC, Tigelaar RE. Environmentally responsive and reversible regulation of epidermal barrier function by gammadelta T cells. J Invest Dermatol 2006;126:808-814.
62. Toulon A, Breton L, Taylor KR, Tenenhaus M, Bhavsar D, Lanigan C et al. A role for human skin-resident T cells in wound healing. J Exp Med 2009;206:743-750.
63. Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Suarez-Farinas M, Fuentes-Duculan J et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 2007;204:3183-3194.
64. Taylor KR, Mills RE, Costanzo AE, Jameson JM. Gammadelta T cells are reduced and rendered unresponsive by hyperglycemia and chronic TNFalpha in mouse models of obesity and metabolic disease. PLoS One 2010;5: e11422.
65. Chiplunkar S, Dhar S, Wesch D, Kabelitz D. gammadelta T cells in cancer immunotherapy: current status and future prospects. Immunotherapy 2009;1:663-678.
66. Bouet-Toussaint F, Cabillic F, Toutirais O, Le Gallo M, Thomas de la Pintiere C, Daniel P et al. Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas. Cancer Immunol Immunother 2008;57:531-539. (Pubitemid 351170536)
67. Bonneville M, Scotet E. Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors. Curr Opin Immunol 2006;18:539-546. (Pubitemid 44311448)
68. Nedellec S, Bonneville M, Scotet E. Human Vgamma9Vdelta2 T cells: from signals to functions. Semin Immunol 2010;22:199-206.